- Total Voting Rights
- Final Results
- Notice of Results
- PRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
- FDA Grants PRTC's LYT-200 Fast Track Designation
- PRTC Launches Seaport w/ $100M; Leadership Changes
- $100M Tender Offer
- $14B Acquisition of PRTC’s Karuna by BMS Completed
- FDA Grants PRTC's LYT-200 Orphan Drug Designation
- PDMR Notification RSU Vesting
More ▼
Key statistics
On Friday, PureTech Health PLC (PRTC:LSE) closed at 219.00, -9.85% below its 52-week high of 242.93, set on Jun 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 214.00 |
---|---|
High | 224.50 |
Low | 214.00 |
Bid | 216.00 |
Offer | 224.00 |
Previous close | 214.00 |
Average volume | 559.13k |
---|---|
Shares outstanding | 269.95m |
Free float | 230.55m |
P/E (TTM) | -- |
Market cap | 590.58m GBP |
EPS (TTM) | -0.188 GBP |
Data delayed at least 20 minutes, as of May 03 2024 16:45 BST.
More ▼
Investors Chronicle View
The last IC recommendation on PureTech Health PLC shares was Buy at 207.00 on 28 Apr 2023Read the full article